Brief: Forward Pharma Says On Aug 22, Got Written Notice From Nasdaq Co's Application To Transfer Listing To Nasdaq Capital Market For ADSs Had Been Approved
Aug 23 (Reuters) - Forward Pharma A/S FWP.O :
* FORWARD PHARMA A/S-ON AUG 22, GOT WRITTEN NOTICE FROM
NASDAQ
CO'S APPLICATION TO TRANSFER LISTING TO NASDAQ CAPITAL MARKET
FOR ADSS HAD BEEN APPROVED
* FORWARD PHARMA A/S - CO'S ADSS TO COMMENCE TRADING ON
NASDAQ
CAPITAL MARKET AT OPENING OF BUSINESS ON AUG 26, 2019 UNDER
SYMBOL “FWP”
Source text: (http://bit.ly/2Z7Agcm)
Further company coverage: FWP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Forward Pharma A/S
See all newsBrief: Forward Pharma- Announces Termination Of Its American Depositary Receipts Facility
U.S. STOCKS ON THE MOVE-Madrigal, Disney, Forward Pharma
Forward Pharma slides to record low on delisting notice from Nasdaq
Brief: Forward Pharma Announces Delisting Its American Depositary Shares From Nasdaq Capital Market
Brief: Forward Pharma A/S Submitted A Request For A Written Decision Regarding Petition For Review Regarding EP2801355 To The EBA